{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T22:08:32Z","timestamp":1785017312448,"version":"3.55.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>There remains controversy regarding the gastrointestinal bleeding (GIB) risk associated with oral anticoagulants (OACs). This retrospective, pharmacovigilance study aimed to systematically assess the risk of OAC-associated GIB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Disproportionality analysis was used for signal detection and subgroup analysis, and multivariable logistic regression was performed based on age, sex, weight, comorbidity, indication, and concomitant drugs. Stratification analysis was further conducted according to GIB location (lower GIB, upper GIB, and unspecified sites).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 24\u00a0421 OAC-associated GIB identified in the FDA adverse event reporting system database, from 2008 Q1 to 2025 Q1. Significant signal of GIB risk was identified in OACs (ROR: 16.56, 95% CI: 16.34\u201316.79, IC025: 3.59), with consistent results across different GIB locations. Direct oral anticoagulants (DOACs) exhibited a lower GIB risk compared to vitamin K antagonists (VKAs); notably, dabigatran demonstrated a heightened risk of lower GIB compared to other OACs. The most prominent signals included hemorrhagic gastroenteritis with edoxaban (IC025: 7.03), intestinal hematoma with VKAs (IC025: 6.34), lower gastrointestinal hemorrhage with dabigatran (IC025: 5.02), gastrointestinal hemorrhage with rivaroxaban (IC025: 4.27), and anal ulcer hemorrhage (IC025: 4.22) with apixaban. Most cases occurred in patients older than 75\u00a0years within first 3\u00a0months of treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>DOACs showed a significantly lower risk of GIB than VKAs, though dabigatran exhibited a higher risk of lower GIB compared to other OACs. Different OACs exhibited distinct risk profiles across GIB locations, providing critical insights for optimizing anticoagulation management strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003675","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:00:30Z","timestamp":1762336830000},"page":"2748-2758","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Oral anticoagulants and gastrointestinal bleeding: pharmacovigilance insights from the FDA adverse event reporting system database"],"prefix":"10.1097","volume":"112","author":[{"given":"Jiale","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Affiliated Jinhua Hospital, Medical College of Zhejiang University\/Jinhua Municipal Hospital, Jinhua, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoquan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Affiliated Jinhua Hospital, Medical College of Zhejiang University\/Jinhua Municipal Hospital, Jinhua, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Longyan Second Hospital, Longyan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Affiliated Jinhua Hospital, Medical College of Zhejiang University\/Jinhua Municipal Hospital, Jinhua, China"},{"name":"School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Affiliated Jinhua Hospital, Medical College of Zhejiang University\/Jinhua Municipal Hospital, Jinhua, China"},{"name":"Department of Pharmacy, Jinhua Second Hospital, Jinhua, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Affiliated Jinhua Hospital, Medical College of Zhejiang University\/Jinhua Municipal Hospital, Jinhua, China"},{"name":"School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1556-4365","authenticated-orcid":false,"given":"Kaili","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People\u2019s Hospital, Quzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"R1-20260512","doi-asserted-by":"crossref","first-page":"100037","DOI":"10.1016\/j.pharmr.2025.100037","article-title":"Anticoagulants: from chance discovery to structure-based design","volume":"77","author":"Chan","year":"2025","journal-title":"Pharmacol Rev"},{"key":"R2-20260512","first-page":"e079520","article-title":"Practical prescribing: direct oral anticoagulants","volume":"386","author":"Khalife","year":"2024","journal-title":"BMJ (Clinical Research Ed)"},{"key":"R3-20260512","doi-asserted-by":"crossref","first-page":"327\u201337","DOI":"10.1146\/annurev-med-050423-085457","article-title":"A rational approach to the treatment of acute pulmonary embolism","volume":"76","author":"Faggioni","year":"2025","journal-title":"Annu Rev Med"},{"key":"R4-20260512","doi-asserted-by":"crossref","first-page":"ezae257","DOI":"10.1093\/ejcts\/ezae257","article-title":"European guidelines on perioperative venous thromboembolism prophylaxis: cardiovascular surgery","volume":"66","author":"Ahmed","year":"2024","journal-title":"Eur J Cardio-thorac Surg"},{"key":"R5-20260512","first-page":"ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"R6-20260512","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"R7-20260512","doi-asserted-by":"crossref","first-page":"ezac488","DOI":"10.1093\/ejcts\/ezac488","article-title":"Joint 2022 European society of thoracic surgeons and the American association for thoracic surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery","volume":"63","author":"Shargall","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"R8-20260512","first-page":"463767","article-title":"Gastrointestinal hemorrhage in warfarin anticoagulated patients: incidence, risk factor, management, and outcome","volume":"2014","author":"Chen","year":"2014","journal-title":"Biomed Res Int"},{"key":"R9-20260512","doi-asserted-by":"crossref","first-page":"439\u201347","DOI":"10.3109\/00365521.2012.763174","article-title":"Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based setting","volume":"48","author":"Hreinsson","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"R10-20260512","doi-asserted-by":"crossref","first-page":"2093\u2013104","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"R11-20260512","doi-asserted-by":"crossref","first-page":"981\u201392","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"R12-20260512","doi-asserted-by":"crossref","first-page":"883\u201391","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"R13-20260512","doi-asserted-by":"crossref","first-page":"1139\u201351","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"R14-20260512","first-page":"651\u201359","article-title":"Direct-acting oral anticoagulants versus warfarin in relation to risk of gastrointestinal bleeding: a systematic review and meta-analysis of randomized controlled trials","volume":"34","author":"Aloysius","year":"2021","journal-title":"Ann Gastroenterol"},{"key":"R15-20260512","doi-asserted-by":"crossref","first-page":"1049283","DOI":"10.3389\/fphar.2022.1049283","article-title":"Comparative differences in the risk of major gastrointestinal bleeding among different direct oral anticoagulants: an updated traditional and bayesian network meta-analysis","volume":"13","author":"Chen","year":"2022","journal-title":"Front Pharmacol"},{"key":"R16-20260512","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cgh.2019.05.056","article-title":"Risk of major gastrointestinal bleeding with new vs conventional oral anticoagulants: a systematic review and meta-analysis","volume":"18","author":"Gu","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R17-20260512","doi-asserted-by":"crossref","DOI":"10.70389\/PJS.100082","article-title":"Transparency in the reporting of artificial INtelligence \u2013 the TITAN guideline","author":"Agha","year":"2025","journal-title":"PJS"},{"key":"R18-20260512","doi-asserted-by":"crossref","first-page":"249\u201358","DOI":"10.1007\/s40264-014-0146-y","article-title":"Performance of probabilistic method to detect duplicate individual case safety reports","volume":"37","author":"Tregunno","year":"2014","journal-title":"Drug Saf"},{"key":"R19-20260512","doi-asserted-by":"crossref","first-page":"1259908","DOI":"10.3389\/fphar.2023.1259908","article-title":"A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?","volume":"14","author":"Cui","year":"2023","journal-title":"Front Pharmacol"},{"key":"R20-20260512","doi-asserted-by":"crossref","first-page":"519\u201323","DOI":"10.1002\/pds.1001","article-title":"The reporting odds ratio and its advantages over the proportional reporting ratio","volume":"13","author":"Rothman","year":"2004","journal-title":"Pharmacoepidem Dr S"},{"key":"R21-20260512","doi-asserted-by":"crossref","first-page":"315\u201321","DOI":"10.1007\/s002280050466","article-title":"A bayesian neural network method for adverse drug reaction signal generation","volume":"54","author":"Bate","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"R22-20260512","doi-asserted-by":"crossref","first-page":"159\u201386","DOI":"10.2165\/00002018-200326030-00003","article-title":"Quantitative methods in pharmacovigilance: focus on signal detection","volume":"26","author":"Hauben","year":"2003","journal-title":"Drug Saf"},{"key":"R23-20260512","first-page":"2027\u201344","article-title":"On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under-reporting on odds ratios","volume":"21","author":"Pgm","year":"2002","journal-title":"Stat Med"},{"key":"R24-20260512","doi-asserted-by":"crossref","first-page":"bbab347","DOI":"10.1093\/bib\/bbab347","article-title":"Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source","volume":"22","author":"Noguchi","year":"2021","journal-title":"Briefings Bioinf"},{"key":"R25-20260512","first-page":"575\u201384","article-title":"The reporting of a disproportionality analysis for drug safety signal detection using individual case safety reports in pharmacovigilance (READUS-PV): development and statement","volume":"47","author":"Fusaroli","year":"2024","journal-title":"Drug Saf"},{"key":"R26-20260512","doi-asserted-by":"crossref","first-page":"573\u201377","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Internal Med"},{"key":"R27-20260512","doi-asserted-by":"crossref","first-page":"1143\u201353","DOI":"10.1007\/s00210-023-02388-7","article-title":"Retrospective analysis of gastrointestinal bleedings with direct oral anticoagulants reported to eudravigilance","volume":"396","author":"Moudallel","year":"2023","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R28-20260512","first-page":"1\u201310","article-title":"Oral anticoagulants-induced intracranial hemorrhage: a real-world pharmacovigilance study over 2008\u20132024","author":"Chen","year":"2024","journal-title":"Expert Opin Drug Saf"},{"key":"R29-20260512","doi-asserted-by":"crossref","first-page":"253\u201360","DOI":"10.1111\/bcp.15491","article-title":"A new model to predict the risk of major gastrointestinal bleeding in patients on direct oral anticoagulants (dabigatran and rivaroxaban)","volume":"89","author":"Lv","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"R30-20260512","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2015.05.002","article-title":"Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: a population-based study","volume":"149","author":"Chan","year":"2015","journal-title":"Gastroenterol"},{"key":"R31-20260512","doi-asserted-by":"crossref","first-page":"1228\u201336","DOI":"10.1080\/00365521.2023.2220460","article-title":"A nomogram for predicting major gastrointestinal bleeding in patients treated with rivaroxaban","volume":"58","author":"Cao","year":"2023","journal-title":"Scand J Gastroenterol"},{"key":"R32-20260512","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.3390\/ijms24086879","article-title":"Challenges of anticoagulant therapy in atrial fibrillation-focus on gastrointestinal bleeding","volume":"24","author":"Scridon","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R33-20260512","doi-asserted-by":"crossref","first-page":"955\u201362","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"R34-20260512","doi-asserted-by":"crossref","first-page":"2494\u2013503","DOI":"10.1161\/STROKEAHA.117.017549","article-title":"Real-world setting comparison of nonvitamin-K antagonist oral anticoagulants versus vitamin-K antagonists for stroke prevention in atrial fibrillation: a systematic review and meta-analysis","volume":"48","author":"Ntaios","year":"2017","journal-title":"Stroke"},{"key":"R35-20260512","doi-asserted-by":"crossref","first-page":"1493\u2013502","DOI":"10.7326\/M21-1474","article-title":"Rivaroxaban is associated with higher rates of gastrointestinal bleeding than other direct oral anticoagulants: a nationwide propensity score\u2013weighted study","volume":"174","author":"Ingason","year":"2021","journal-title":"Ann Intern Med"},{"key":"R36-20260512","doi-asserted-by":"crossref","first-page":"463\u201373","DOI":"10.7326\/M19-2522","article-title":"Effectiveness and safety of apixaban compared with rivaroxaban for patients with atrial fibrillation in routine practice: a cohort study","volume":"172","author":"Fralick","year":"2020","journal-title":"Ann Intern Med"},{"key":"R37-20260512","doi-asserted-by":"crossref","first-page":"e005362","DOI":"10.1161\/JAHA.116.005362","article-title":"Comparative effectiveness and safety of dabigatran and rivaroxaban in atrial fibrillation patients","volume":"6","author":"Lai","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R38-20260512","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/jpm9010007","article-title":"Pharmacogenomics of novel direct oral anticoagulants: newly identified genes and genetic variants","volume":"9","author":"Kanuri","year":"2019","journal-title":"J Pers Med"},{"key":"R39-20260512","doi-asserted-by":"crossref","first-page":"375\u201394","DOI":"10.4330\/wjc.v15.i8.375","article-title":"Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: a cardiologic point of view","volume":"15","author":"Abrignani","year":"2023","journal-title":"World J Cardiol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:16:20Z","timestamp":1778580980000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003675","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"2025-06-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}